Samuel Backenroth

Chief Executive Officer, NeuBase Therapeutics, Inc.

Companies

Notable Labs, Ltd.Chief financial officer Jan 3, 2023 to Apr 18, 2023¹
NeuBase Therapeutics, Inc.Chief financial officer Dec 8, 2014 to Dec 30, 2020²
NeuBase Therapeutics, Inc.Chief executive officer Jun 24, 2013 to Jun 24, 2013³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Notable Labs, Ltd.525,000 shares⁴Mar 31, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 31, 2023Exercised options 525,000 shares of Notable Labs, Ltd.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNotable Labs, Ltd., Chief financial officer
2
SEC EDGARNeuBase Therapeutics, Inc., Chief financial officer
3
SEC EDGARNeuBase Therapeutics, Inc., Chief executive officer
4
SEC EDGARNotable Labs, Ltd. shares after the filing of Mar 31, 2023